SELECTION OF A SLOW-RELEASE THEOPHYLLINE PRODUCT

被引:25
作者
HENDELES, L
WEINBERGER, M
机构
[1] UNIV FLORIDA,DEPT PEDIAT,DIV CLIN PHARMACOL,GAINESVILLE,FL 32610
[2] UNIV IOWA,DIV PEDIAT ALLERGY & PULM,IOWA CITY,IA 52242
关键词
D O I
10.1016/0091-6749(86)90055-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:743 / 751
页数:9
相关论文
共 34 条
[1]  
BAKER JR, 1985, J ALLERGY CLIN IMMUN, V75, P106
[2]  
FAGERSTROM PO, 1983, INT J CLIN PHARM TH, V21, P359
[3]   RELATIONSHIP OF THEOPHYLLINE CLEARANCE TO ORAL DOSAGE IN CHILDREN WITH CHRONIC ASTHMA [J].
GINCHANSKY, E ;
WEINBERGER, M .
JOURNAL OF PEDIATRICS, 1977, 91 (04) :655-660
[4]   THEOPHYLLINE ABSORPTION IN YOUNG ASTHMATIC-CHILDREN RECEIVING SUSTAINED-RELEASE FORMULATIONS [J].
HALTOM, JR ;
SZEFLER, SJ .
JOURNAL OF PEDIATRICS, 1985, 107 (05) :805-810
[5]   FOOD-INDUCED DOSE-DUMPING FROM A ONCE-A-DAY THEOPHYLLINE PRODUCT AS A CAUSE OF THEOPHYLLINE TOXICITY [J].
HENDELES, L ;
WEINBERGER, M ;
MILAVETZ, G ;
HILL, M ;
VAUGHAN, L .
CHEST, 1985, 87 (06) :758-765
[6]   A CLINICAL AND PHARMACOKINETIC BASIS FOR THE SELECTION AND USE OF SLOW RELEASE THEOPHYLLINE PRODUCTS [J].
HENDELES, L ;
IAFRATE, RP ;
WEINBERGER, M .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :95-135
[7]   ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE [J].
HENDELES, L ;
WEINBERGER, M ;
BIGHLEY, L .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05) :525-527
[8]  
HENDELES L, 1983, PHARMACOTHERAPY, V3, P2
[9]   DISPOSITION AND CLINICAL PHARMACOKINETICS OF MICROCRYSTALLINE THEOPHYLLINE [J].
JONKMAN, JHG ;
BERG, WC ;
SCHOENMAKER, R ;
DEZEEUW, RA ;
GREVING, JE ;
ORIE, NGM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (05) :379-384
[10]   FOOD-INDUCED CHANGES IN THEOPHYLLINE ABSORPTION FROM CONTROLLED-RELEASE FORMULATIONS .1. SUBSTANTIAL INCREASED AND DECREASED ABSORPTION WITH UNIPHYL TABLETS AND THEO-DUR SPRINKLE [J].
KARIM, A ;
BURNS, T ;
WEARLEY, L ;
STREICHER, J ;
PALMER, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (01) :77-83